This topic contains a solution. Click here to go to the answer

Author Question: A ________ is defined as a network of value-creating activities. A) value segment B) value ... (Read 28 times)

ishan

  • Hero Member
  • *****
  • Posts: 546
A ________ is defined as a network of value-creating activities.
 
  A) value segment
  B) value pyramid
  C) value chain
  D) value system

Question 2

A type of message in which the caller has to wait for the receiving object to finish executing the called operation before it can resume execution itself is a(n):
 
  A) synchronous message.
  B) simple message.
  C) asynchronous message.
  D) half-duplex message.
  E) packet.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

vickybb89

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

C

Answer to Question 2

A
Explanation: A) A synchronous message, shown as a solid arrowhead, is one for which the caller has to wait for the receiving object to complete executing the called operation before it itself can resume execution.
CL




ishan

  • Member
  • Posts: 546
Reply 2 on: Jul 7, 2018
Gracias!


bblaney

  • Member
  • Posts: 323
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

Bacteria have flourished on the earth for over three billion years. They were the first life forms on the planet.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library